Islet cell hyperexpression of HLA class I antigens: a defining feature in type 1 diabetes
2016 · Diabetologia · 286 citations
https://doi.org/10.1007/s00125-016-4067-4
L
Lars Krogvold
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
72
Papers
3.1K
Citations
27
h-index
36
i10-index
Lars Krogvold is an academic researcher from Oslo University Hospital. The author has contributed to research in topics: Diabetes and associated disorders & Pancreatic function and diabetes & Diabetes Management and Research. The author has an h-index of 27, co-authored 62 publications.
ORCID: 0000-0002-1057-7095Papers by this author
worksPDL1 is expressed in the islets of people with type 1 diabetes and is up-regulated by interferons-α and-γ via IRF1 induction
2018 · EBioMedicine · 181 citations
https://doi.org/10.1016/j.ebiom.2018.09.040
Abnormal islet sphingolipid metabolism in type 1 diabetes
2018 · Diabetologia · 84 citations
https://doi.org/10.1007/s00125-018-4614-2
Clinical aspects of a nationwide epidemic of severe haemolytic uremic syndrome (HUS) in children
2011 · Scandinavian Journal of Trauma Resuscitation and Emergency Medicine · 20 citations
https://doi.org/10.1186/1757-7241-19-44
NF-κB activity during pancreas development regulates adult β-cell mass by modulating neonatal β-cell proliferation and apoptosis
2021 · Cell Death Discovery · 11 citations
https://doi.org/10.1038/s41420-020-00386-9
Characterisation of HNF1A variants in paediatric diabetes in Norway using functional and clinical investigations to unmask phenotype and monogenic diabetes
2023 · Diabetologia · 6 citations
https://doi.org/10.1007/s00125-023-06012-4
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat